Jinque Luo

826 total citations
28 papers, 541 citations indexed

About

Jinque Luo is a scholar working on Molecular Biology, Surgery and Immunology. According to data from OpenAlex, Jinque Luo has authored 28 papers receiving a total of 541 indexed citations (citations by other indexed papers that have themselves been cited), including 15 papers in Molecular Biology, 5 papers in Surgery and 5 papers in Immunology. Recurrent topics in Jinque Luo's work include Sirtuins and Resveratrol in Medicine (4 papers), Cholesterol and Lipid Metabolism (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Jinque Luo is often cited by papers focused on Sirtuins and Resveratrol in Medicine (4 papers), Cholesterol and Lipid Metabolism (4 papers) and Cancer, Lipids, and Metabolism (3 papers). Jinque Luo collaborates with scholars based in China, United States and Germany. Jinque Luo's co-authors include Shuyi Si, Yanni Xu, Yufeng Xia, Zheng Gen Jin, Suowen Xu, Yannong Dou, Bei Tong, Yan Yang, Huan Liu and Xiaoqian Wu and has published in prestigious journals such as Circulation Research, The FASEB Journal and Biochemical and Biophysical Research Communications.

In The Last Decade

Jinque Luo

27 papers receiving 534 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Jinque Luo China 14 233 80 65 63 58 28 541
Changwu Xu China 16 344 1.5× 105 1.3× 70 1.1× 55 0.9× 118 2.0× 33 758
Junmei Ye China 14 223 1.0× 48 0.6× 27 0.4× 63 1.0× 81 1.4× 27 431
Julie A. Douthwaite United Kingdom 14 300 1.3× 69 0.9× 49 0.8× 50 0.8× 80 1.4× 24 774
Ziyu Meng China 14 281 1.2× 86 1.1× 89 1.4× 131 2.1× 28 0.5× 35 671
Balázs Radnai Hungary 13 208 0.9× 116 1.4× 49 0.8× 31 0.5× 27 0.5× 23 498
Lihua Li China 17 306 1.3× 153 1.9× 79 1.2× 104 1.7× 84 1.4× 42 717
Shuying Miao China 12 222 1.0× 51 0.6× 35 0.5× 68 1.1× 17 0.3× 22 526
Yu Tao China 19 376 1.6× 122 1.5× 49 0.8× 94 1.5× 20 0.3× 28 786

Countries citing papers authored by Jinque Luo

Since Specialization
Citations

This map shows the geographic impact of Jinque Luo's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Jinque Luo with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Jinque Luo more than expected).

Fields of papers citing papers by Jinque Luo

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Jinque Luo. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Jinque Luo. The network helps show where Jinque Luo may publish in the future.

Co-authorship network of co-authors of Jinque Luo

This figure shows the co-authorship network connecting the top 25 collaborators of Jinque Luo. A scholar is included among the top collaborators of Jinque Luo based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Jinque Luo. Jinque Luo is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Luo, Jinque, Ling Wang, Li Zhang, et al.. (2025). Targeting adipocyte differentiation with CRT0066101: activation of AMPK signaling in 3T3-L1 cells. Frontiers in Pharmacology. 16. 1645587–1645587.
2.
Luo, Jinque, Li Zhang, Jie Zhao, et al.. (2025). 5-deoxy-rutaecarpine protects against LPS-induced acute lung injury via inhibiting NLRP3 inflammasome-related inflammation. Frontiers in Pharmacology. 16. 1522146–1522146. 7 indexed citations
3.
Li, Shunwang, Jinque Luo, Huan Liu, et al.. (2024). ASGR1 Deficiency Inhibits Atherosclerosis in Western Diet–Fed ApoE −/− Mice by Regulating Lipoprotein Metabolism and Promoting Cholesterol Efflux. Arteriosclerosis Thrombosis and Vascular Biology. 44(12). 2428–2449. 9 indexed citations
4.
Luo, Jinque, Huan Liu, Yanni Xu, et al.. (2024). Hepatic Sirt6 activation abrogates acute liver failure. Cell Death and Disease. 15(4). 283–283. 7 indexed citations
5.
Wang, Lingling, Xin Li, Xiaoju Men, Xiangyi Liu, & Jinque Luo. (2024). Research progress on antioxidants and protein aggregation inhibitors in cataract prevention and therapy (Review). Molecular Medicine Reports. 31(1). 22 indexed citations
6.
Luo, Jinque, et al.. (2024). MicroRNA-19a-3p inhibits endothelial dysfunction in atherosclerosis by targeting JCAD. BMC Cardiovascular Disorders. 24(1). 394–394. 21 indexed citations
7.
Wang, Weizhi, Chao Liu, Jinque Luo, et al.. (2024). A novel small-molecule PCSK9 inhibitor E28362 ameliorates hyperlipidemia and atherosclerosis. Acta Pharmacologica Sinica. 45(10). 2119–2133. 38 indexed citations
8.
Li, Xin, Jinque Luo, Shuo Zhang, et al.. (2024). Allicin inhibits the growth of HONE-1 and HNE1 human nasopharyngeal carcinoma cells by inducing ferroptosis. Neoplasma. 71(3). 243–254. 30 indexed citations
9.
Wang, Jinping, Jinque Luo, Dante Rotili, et al.. (2023). SIRT6 Protects Against Lipopolysaccharide-Induced Inflammation in Human Pulmonary Lung Microvascular Endothelial Cells. Inflammation. 47(1). 323–332. 16 indexed citations
10.
Wu, Xiaoqian, Huan Liu, Suowen Xu, et al.. (2022). SIRT6 Mitigates Heart Failure With Preserved Ejection Fraction in Diabetes. Circulation Research. 131(11). 926–943. 56 indexed citations
11.
Li, Yining, Weizhi Wang, Xiaowan Han, et al.. (2020). Nuclear Factor Erythroid 2 Related Factor 2 Activator JC-5411 Inhibits Atherosclerosis Through Suppression of Inflammation and Regulation of Lipid Metabolism. Frontiers in Pharmacology. 11. 532568–532568. 15 indexed citations
12.
Luo, Jinque, et al.. (2019). Regulation of SRF protein stability by an autophagy-dependent pathway. Biochemical and Biophysical Research Communications. 521(2). 279–284. 6 indexed citations
13.
Zuo, Xuan, et al.. (2019). The anti-atherosclerotic effect and mechanism study of berberine in hyperlipidemic ApoE-/- mice.. Yaoxue xuebao. 54(1). 104–110. 1 indexed citations
14.
Dou, Yannong, Jinque Luo, Juntao Yu, Yufeng Xia, & Yue Dai. (2019). Cholinergic system is involved in the therapeutic effect of madecassoside on collagen-induced arthritis in rats. International Immunopharmacology. 75. 105813–105813. 11 indexed citations
15.
Xu, Suowen, Yanni Xu, Peng Liu, et al.. (2019). The novel coronary artery disease risk gene JCAD/KIAA1462 promotes endothelial dysfunction and atherosclerosis. European Heart Journal. 40(29). 2398–2408. 69 indexed citations
16.
Feng, Tingting, Peng Liu, Jinque Luo, et al.. (2018). SIRT1 activator E1231 protects from experimental atherosclerosis and lowers plasma cholesterol and triglycerides by enhancing ABCA1 expression. Atherosclerosis. 274. 172–181. 25 indexed citations
17.
Dou, Yannong, Jinque Luo, Xin Wu, et al.. (2018). Curcumin attenuates collagen-induced inflammatory response through the “gut-brain axis”. Journal of Neuroinflammation. 15(1). 6–6. 31 indexed citations
20.
Luo, Jinque, Mei Liu, Xin Wu, et al.. (2015). DGAEE, a newly synthesized derivative of glycyrrhetinic acid, potently attenuates mouse septic shock via its main metabolite DGA in an IL-10-dependent manner. International Immunopharmacology. 29(2). 583–590. 5 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026